How have FDBK shares performed in 2023?

Feedback's stock was trading at GBX 97.50 at the beginning of the year. Since then, FDBK stock has decreased by 26.2% and is now trading at GBX 72. View the best growth stocks for 2023 here .

How were Feedback's earnings last quarter?

Feedback plc (LON:FDBK) released its earnings results on Tuesday, February, 18th. The company reported ($26.00) EPS for the quarter. Feedback had a negative trailing twelve-month return on equity of 23.75% and a negative net margin of 284.70%.

When did Feedback's stock split?

Feedback's stock reverse split before market open on Friday, October 14th 2022. The 1-200 reverse split was announced on Friday, October 14th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, October 14th 2022. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

What other stocks do shareholders of Feedback own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Feedback investors own include Quadrise Fuels International (QFI) , Apple Hospitality REIT (APLE) , Advanced Oncotherapy (AVO) , Deltic Energy Plc (CLNR.L) (CLNR) , Haydale Graphene Industries (HAYD) , Ilika (IKA) , Open Text (OTEX) , Prospect Capital (PSEC) , Remote Monitored Systems (RMS) and 21512 (SAT.L) (SAT) .

How do I buy shares of Feedback?

Shares of FDBK stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

Feedback Share Price, News & Analysis (LON:FDBK)

GBX 72

0.00 (0.00%)

(As of 11/28/2023 ET)

Compare

Today's Range: 70
▼
72.80
50-Day Range: 71.50
▼
85
52-Week Range: 70
▼
184.90

Volume: 5,085 shs
Average Volume: 14,231 shs
Market Capitalization: £9.60 million

P/E Ratio: N/A
Dividend Yield: 4.56%
Price Target: N/A

Stock Analysis Chart Competitors Headlines

About Feedback Stock (LON:FDBK)

Feedback plc, a medical imaging technology company, engages in the provision of software and systems to those working in the field of medical imaging. Its products include Bleepa, a secure clinical communications and data viewing platform that facilitates the sharing of clinical-grade medical images; CareLocker, a patient centric cloud architecture that provides secure data portability; and Bleepa Box, a technology for sharing DICOM images and other clinical data over mobile networks with the company's dedicated cloud environment, CareLocker, for subsequent display and review within Bleepa. The company also offers Cadran, a picture archiving storage, management, and display system for medical images; TexRAD, a patent-protected algorithm that extracts and quantifies texture features in pre-existing medical images; and TexRAD Lung, a software tool for the analysis of lung cancer for clinical use. Feedback plc was incorporated in 1958 and is headquartered in London, the United Kingdom.

FDBK Stock Price History

30 days | 90 days | 365 days | Advanced Chart

FDBK Stock News Headlines

November 26, 2023 | americanbankingnews.com

Feedback (LON:FDBK) Hits New 52-Week Low at $70.00

October 27, 2023 | sfgate.com

Writing groups spark creativity, provide feedback

November 28, 2023 | RYSE INC. (Ad)

Secure your stake in the Smart Home industry.

Last chance to invest in RYSE – the shade automation technology launching in over 100 Best Buy stores this month.

June 6, 2023 | forbes.com

Five Steps To Get Honest Feedback

May 24, 2023 | forbes.com

Hard Feedback Is The Most Generous Act Of Leadership

April 18, 2023 | forbes.com

How To Give Feedback On Someone's Appearance

March 23, 2023 | finance.yahoo.com

We Think Feedback (LON:FDBK) Can Afford To Drive Business Growth

March 10, 2023 | bbc.co.uk

Types of feedback - intrinsic and extrinsic

November 28, 2023 | Autonomix (Ad)

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

March 1, 2023 | cbsnews.com

Boulder wants feedback on snow removal in the city

October 14, 2022 | finance.yahoo.com

We're Interested To See How Feedback (LON:FDBK) Uses Its Cash Hoard To Grow

September 4, 2022 | lse.co.uk

2022-23 First Quarter Fiscal Update

September 3, 2022 | lse.co.uk

Update on proposed refinance and redemption

September 3, 2022 | lse.co.uk

Capital Metals Share Chat

August 6, 2022 | lse.co.uk

China's Sanya holiday hotspot shuts duty-free malls, venues to curb COVID

June 1, 2022 | proactiveinvestors.com.au

Feedback sees full-year revenue ‘materially ahead’ of market forecasts

May 1, 2022 | lse.co.uk

TOP NEWS: NatWest income surges in first quarter and improves outlook

April 16, 2022 | yahoo.com

National Water Dance to return April 23

April 15, 2022 | lse.co.uk

ImmuPharma surges on success in latest trial of lupus treatment

April 15, 2022 | finance.yahoo.com

Here's Why We're Not Too Worried About Feedback's (LON:FDBK) Cash Burn Situation

April 12, 2022 | proactiveinvestors.com.au

UK unemployment back to pre-pandemic level but employment remains flat as people leave workforce

April 12, 2022 | proactiveinvestors.com

Feedback wins two more NHS contracts for Bleepa app

April 2, 2022 | proactiveinvestors.com.au

Proactive weekly oil and gas highlights: Pantheon, COPL, Chariot, 88 Energy and more

April 1, 2022 | lse.co.uk

Mainz Biomed Completes Successful Pre-Submission Process with the U.S FDA for ColoAlert's Pivotal Clinical Trial

March 31, 2022 | proactiveinvestors.com.au

Feedback says its Bleepa TB screening service goes live in India’s Evangelical Hospital Khariar

February 3, 2022 | lse.co.uk

Issue of WisdomTree Commodity Securities Limited

January 27, 2022 | lse.co.uk

IMF downgrades expectations for global economic recovery in 2022

See More Headlines

Receive FDBK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Feedback and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/18/2020
Today: 11/28/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: LON
Industry: Health Information Services
Sub-Industry: N/A
Sector: Medical
Current Symbol: LON:FDBK
CUSIP: N/A
CIK: N/A
Web: www.fbk.com
Phone: +44-1954-718072
Fax: N/A
Employees: 24
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): GBX (0.22)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: £-2,920,000.00
Net Margins: -284.70%
Pretax Margin: N/A
Return on Equity: -23.75%
Return on Assets: -16.43%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 9.35
Quick Ratio: 18.41

Sales & Book Value

Annual Sales: £1.02 million
Price / Sales: 9.41
Cash Flow: GBX 64.34 per share
Price / Cash Flow: 1.12
Book Value: GBX 81 per share
Price / Book: 0.89

Miscellaneous

Outstanding Shares: 13,330,000
Free Float: N/A
Market Cap: £9.60 million
Optionable: Not Optionable
Beta: 0.91

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

Dr. Thomas James Oakley B.Sc. (Age 34)
CEO & Director
Comp: $210.67k
Mr. Aneshkumar Ishwarbhai Patel C.A. (Age 41)
CFO, Company Secretary & Director
Comp: $177.35k
Mr. Stephen McAteer
Chief Operating Officer
Mr. Michael Peter Hayball (Age 56)
Chief Technology Officer
Comp: $94.75k
Dr. Stephen Brown
Chief Information Officer
Ms. Sarah Bricknell
Commercial and Legal Advisor
Mr. Nicolas Mayhew
Chief Sales & Marketing Officer

Key Competitors

View All Competitors

Insiders

FDBK Stock Analysis - Frequently Asked Questions

How have FDBK shares performed in 2023?: Feedback's stock was trading at GBX 97.50 at the beginning of the year. Since then, FDBK stock has decreased by 26.2% and is now trading at GBX 72.
View the best growth stocks for 2023 here.
How were Feedback's earnings last quarter?: Feedback plc (LON:FDBK) released its earnings results on Tuesday, February, 18th. The company reported ($26.00) EPS for the quarter. Feedback had a negative trailing twelve-month return on equity of 23.75% and a negative net margin of 284.70%.
When did Feedback's stock split?: Feedback's stock reverse split before market open on Friday, October 14th 2022. The 1-200 reverse split was announced on Friday, October 14th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, October 14th 2022. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

What other stocks do shareholders of Feedback own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Feedback investors own include Quadrise Fuels International (QFI), Apple Hospitality REIT (APLE), Advanced Oncotherapy (AVO), Deltic Energy Plc (CLNR.L) (CLNR), Haydale Graphene Industries (HAYD), Ilika (IKA), Open Text (OTEX), Prospect Capital (PSEC), Remote Monitored Systems (RMS) and 21512 (SAT.L) (SAT).
How do I buy shares of Feedback?: Shares of FDBK stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:FDBK) was last updated on 11/28/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial